Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cancer Patients
90%
In Cancer
70%
Patients with Cancer
61%
Comprehensive Cancer Center
50%
Hospitalist
45%
30-day Readmission
42%
Readmission Risk
42%
Hospitalization
33%
Readmission
32%
Cancer Pain
29%
Readmission Rate
27%
Solid Tumors
26%
External Validation
26%
Malignant Solid Tumor
24%
Clinical Practice Guidelines
21%
Congestive Heart Failure
21%
Pain Management
21%
Value Associations
21%
Medical Marijuana
21%
Cancer Therapy
21%
Cannabidiol
21%
Cardiovascular Toxicity
21%
Oral Oncology
21%
Transesophageal
21%
Multinational Association of Supportive Care in Cancer
21%
Risk Scoring System
21%
Catheter
21%
Transabdominal
21%
Attitude of Health Personnel
21%
Mucositis
21%
Unplanned Readmission
21%
Malignant Bowel Obstruction
21%
Toxicity Risk
21%
Gastrostomy
21%
Palliation
21%
Left Ventricular Ejection Fraction
21%
Decompression
21%
International Society
21%
Clinical Oncology
21%
General Internal Medicine
21%
American College of Physicians
21%
Targeted Agents
21%
Meta-analysis
21%
Hospital-Based Clinical Medicine
21%
Sleeping Disease
21%
Delirium Prediction
21%
Prediction Tool
21%
Oncology
21%
Receptor Agonist
21%
Immune Effectors
21%
Nursing and Health Professions
Malignant Neoplasm
100%
Cancer Center
48%
Hospital Readmission
48%
Medical Staff
42%
Health Care Personnel
42%
Efficacy
42%
Cancer Pain
26%
Solid Malignant Neoplasm
24%
Palliative Therapy
22%
Opioid
22%
Lung Cancer
21%
Cannabidiol
21%
Scoring System
21%
Medical Cannabis
21%
Delirium
21%
Intestine Obstruction
21%
COVID-19
21%
Catheter
21%
Accident Prevention
21%
Physical Activity
21%
Diarrhea
21%
Analgesic Agent
21%
Hypertension
21%
Meta Analysis
21%
Constipation
21%
Hydromorphone
21%
Gastrostomy
17%
Counseling
15%
Side Effect
14%
Length of Stay
13%
Ascites
10%
Clinical Trial
10%
Diseases
9%
Emergency Ward
8%
Health Care Quality
8%
Intraocular Lens
8%
Infusion
8%
Receiver Operating Characteristic
8%
Mucosa Inflammation
7%
Sample Size
7%
Gastrostomy Catheter
7%
Bevacizumab
7%
Oral Mucositis
7%
Sorafenib
7%
Number Needed to Harm
7%
Early Intervention
7%
Food and Drug Administration
7%
Sunitinib
7%
Gastrointestinal Toxicity
7%
Erlotinib
7%
Medicine and Dentistry
Malignant Neoplasm
39%
Mucositis
26%
Adverse Event
25%
Hospitalist
21%
Lung Cancer
21%
Solid Malignant Neoplasm
21%
Cancer Pain
21%
Symptomatic Treatment
21%
Cancer Therapy
21%
Supportive Care
21%
Oral Oncology
21%
Bowel Obstruction
21%
Meta-Analysis
21%
Bayesian Information Criterion
21%
Colon Carcinoma
21%
Cancer Diagnosis
21%
Pulmonary Embolism
21%
Base
21%
Lead Poisoning
21%
Gastrostomy
21%
Analgesic Efficacy
21%
Hydromorphone
21%
Immune-Related Adverse Events
21%
Immunotherapy
21%
Toxicity and Intoxication
21%
Cytokine Release Syndrome
21%
Oral
21%
Diarrhea
15%
Small Cell Lung Cancer
14%
Pulmonary Angiography
13%
Risk Stratification
12%
Clinical Significance
10%
Side Effect
10%
Ascites
9%
Bone Turnover
8%
Infusion
8%
Intraocular Lens
8%
Oral Mucositis
8%
D-Dimer
7%
Overall Survival
7%
T Cell
7%
Immune Checkpoint Inhibitor
7%
Systematic Review
6%
English (Language)
5%
Early Intervention
5%
Sorafenib
5%
Gastrointestinal Toxicity
5%
Randomized Clinical Trials
5%
Sunitinib
5%
Bevacizumab
5%